SCHEMBL8345384

SCHEMBL8345384

NC(C(=O)Nc1cccc2ccccc12)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
GAA P10253 2/20 0.60
MAPT P10636 2/20 0.58
ALDH1A1 P00352 2/20 0.56
RAB9A P51151 5/20 0.55
NPC1 O15118 4/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
POLB P06746 2/20 0.54
GSK3B P49841 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
ROCK2 O75116 1/20 0.49
CDC42 P60953 1/20 0.49
ROCK1 Q13464 1/20 0.49
PKN2 Q16513 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28611344 1.00 KDM4E (0.60) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL28017454 0.83 KDM4E (0.59) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL8861385 0.81 KDM4E (0.60) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL8861384 0.81 KDM4E (0.60) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL19549091 0.81 IDO1 (0.65) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL3250896 0.81 IDO1 (0.65) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL28619493 0.80 KDM4E (0.62) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL27295441 0.79 KDM4E (0.57) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL27295439 0.79 KDM4E (0.57) KDM4EGAAMAPTALDH1A1RAB9A
SCHEMBL6718145 0.79 MEN1 (0.63) KDM4EMAPTALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110041285-B Preparation method of 2, 4, 5-trisubstituted oxazole compound 大连理工大学 2021-08-20 CN disclosed
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed